Spinal-Cord Injury Therapy OK'd By FDA Could Lead To Cures
The Food and Drug Administration has approved a phase 1 clinical trial to evaluate the safety of transplanting human Schwann cells to treat patients with paralysis [5]. It is the first such trial in the world.